TrialThe British journal of psychiatry : the journal of mental science2023

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.

Colleen Loo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.